Known targets — ChEMBL curated mechanism
The experimentally established mechanism targets of Sulfuric Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 1/20 | 0.42 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.42 |
| ▸ | TSHR | P16473 | 1/20 | 0.42 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.42 |
| ▸ | TP53 | P04637 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Sulfuric Acid SCHEMBL28481614 | 1.00 | MEN1 (0.42) | MEN1ALDH1A1TSHRKMT2ATP53 | |
| Sulfuric Acid SCHEMBL6665121 | 1.00 | — | — | |
| Sulfuric Acid SCHEMBL28413166 | 1.00 | MEN1 (0.42) | MEN1ALDH1A1TSHRKMT2ATP53 | |
| Sulfuric Acid SCHEMBL66364 | 1.00 | — | — | |
| Sulfuric Acid SCHEMBL451999 | 1.00 | MEN1 (0.42) | MEN1ALDH1A1TSHRKMT2ATP53 | |
| Sulfuric Acid SCHEMBL8996511 | 1.00 | MEN1 (0.42) | MEN1ALDH1A1TSHRKMT2ATP53 | |
| Sulfuric Acid SCHEMBL28609918 | 1.00 | MEN1 (0.42) | MEN1ALDH1A1TSHRKMT2ATP53 | |
| Sulfuric Acid SCHEMBL66658 | 1.00 | MEN1 (0.42) | MEN1ALDH1A1TSHRKMT2ATP53 | |
| Sulfuric Acid SCHEMBL51725 | 1.00 | — | — | |
| Sulfuric Acid SCHEMBL28635025 | 1.00 | MEN1 (0.42) | MEN1ALDH1A1TSHRKMT2ATP53 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 76 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12305286-B2 | Metal sheet treatment method and metal sheet treated with this method | ARCELORMITTAL (LU) | 2025-05-20 | — | — | US | claimed |
| CN-117884105-A | Preparation method of formaldehyde-purifying high-strength gypsum powder, product and application thereof | 中国石油化工股份有限公司 | 2024-04-16 | — | — | CN | claimed |
| US-20240093375-A1 | Metal sheet treatment method and metal sheet treated with this method | ARCELORMITTAL (LU) | 2024-03-21 | — | — | US | claimed |
| EP-4045696-B1 | METAL SHEET TREATMENT METHOD AND METAL SHEET TREATED WITH THIS METHOD | ARCELORMITTAL (LU) | 2023-11-29 | — | — | EP | claimed |
| EP-4045696-A1 | METAL SHEET TREATMENT METHOD AND METAL SHEET TREATED WITH THIS METHOD | ArcelorMittal (LU) | 2022-08-24 | — | — | EP | claimed |
| CN-114555862-A | Method for treating metal plate and metal plate treated by the method | 安赛乐米塔尔公司 | 2022-05-27 | — | — | CN | claimed |
| CN-108486209-B | Method for rapidly screening (R) -2- (4-hydroxyphenoxy) propionic acid producing strains in high flux | 浙江工业大学 | 2022-03-18 | — | — | CN | claimed |
| CN-111133123-B | Method for treating metal plate and metal plate treated by the method | 安赛乐米塔尔公司 | 2021-12-03 | — | — | CN | claimed |
| CN-109536392-B | Aspergillus versicolor ZJB16085 and application thereof in synthesis of R-2- (4-hydroxyphenoxy) propionic acid | 浙江工业大学 | 2021-07-27 | — | — | CN | claimed |
| CN-109609389-B | Penicillium oxalicum ZJB16086 and application thereof in synthesis of R-2- (4-hydroxyphenoxy) propionic acid | 浙江工业大学 | 2021-07-27 | — | — | CN | claimed |
| CN-108823098-B | High-throughput screening method of R-2- (4-hydroxyphenoxy) propionic acid synthetic strain | 浙江工业大学 | 2021-04-06 | — | — | CN | claimed |
| CN-111013622-B | Z-type graphitized carbon nitride/carbon/sulfur-doped graphitized carbon nitride composite material and preparation method thereof | 中国石油大学(北京) | 2021-02-23 | — | — | CN | claimed |
| CN-107568061-B | Method for promoting accumulation of rosmarinic acid in hairy roots of salvia miltiorrhiza | 浙江理工大学 | 2020-09-01 | — | — | CN | claimed |
| CN-111133123-A | Method for treating metal plate and metal plate treated by the method | 安赛乐米塔尔公司 | 2020-05-08 | — | — | CN | claimed |
| CN-111094614-A | Method for treating metal plate and metal plate treated by the method | 安赛乐米塔尔公司 | 2020-05-01 | — | — | CN | claimed |
| CN-111013622-A | Z-type graphitized carbon nitride/carbon/sulfur-doped graphitized carbon nitride composite material and preparation method thereof | 中国石油大学(北京) | 2020-04-17 | — | — | CN | claimed |
| CN-108823098-A | A kind of high-throughput screening method of R-2- (4- hydroxyphenoxy) propionic acid synthesis bacterial strain | 浙江工业大学 | 2018-11-16 | — | — | CN | claimed |
| CN-108486209-A | A kind of method of high-flux fast screening high yield R-2- (4- hydroxyphenoxies) propionic acid bacterial strain | 浙江工业大学 | 2018-09-04 | — | — | CN | claimed |
| US-12441751-B2 | Metabolic labeling and molecular enhancement of biological materials using bioorthogonal reactions | THE GENERAL HOSPITAL CORPORATION (US) | 2025-10-14 | — | — | US | disclosed |
| EP-0964467-A2 | Manganese dioxide/zinc rechargeable cell with improved capacity and reversibility | Finecell CO. LTD. (KR) | 1999-12-15 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12441751-B2 | Metabolic labeling and molecular enhancement of biological materials using bioorthogonal reactions | GALNT14, NEU4, CSGALNACT1 | MEN1 4631/4885ALDH1A1 437/4885TSHR 3743/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.